Results 131 to 140 of about 2,958 (159)

BRCA1 and BRCA2 Mutations in Polish Women with Ductal Carcinoma In Situ. [PDF]

Cancers (Basel)
Feszak S, Feszak IJ, Kluźniak W, Wokołorczyk D, Stempa K, Gliniewicz K, Uciński J, Huzarski T, Dębniak T, Gronwald J, Lubiński J, Narod SA, Cybulski C.   +12 more
europepmc   +1 more source

Delineating the relationship between circulating osteoprotegerin and bone health in women with a pathogenic variant in BRCA1: A cross-sectional analysis. [PDF]

Bone Rep
Mokhber A, Hall E, Uzelac A, Salmena L, Cheung A, Lubinski J, Narod SA, Kotsopoulos J.   +7 more
europepmc   +1 more source

Benchmarking genetic interaction scoring methods for identifying synthetic lethality from combinatorial CRISPR screens. [PDF]

NAR Genom Bioinform
Ajmal H, Nandi S, Kebabci N, Ryan CJ.
europepmc   +1 more source

Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers. [PDF]

J Natl Cancer Inst
Narod SA, Gronwald J, Karlan B, Moller P, Huzarski T, Tung N, Aeilts A, Eisen A, Armel SR, Singer CF, Foulkes WD, Neuhausen SL, Olopade O, Pal T, Fruscio R, Metcalfe K, Raj R, Jacobson M, Sun P, Lubinski J, Kotsopoulos J.   +20 more
europepmc   +1 more source

The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations. [PDF]

Hered Cancer Clin Pract
Narod SA, Metcalfe K, Finch A, Chan AW, Armel SR, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Foulkes WD, Neuhausen SL, Eng C, Olopade O, Zakalik D, Couch F, Cullinane C, Pal T, Sun P, Kotsopoulos J, Hereditary Breast Cancer Clinical Research Group.   +20 more
europepmc   +1 more source

Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancer. [PDF]

BJC Rep
Pederson HJ, Narod SA.
europepmc   +1 more source

Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers. [PDF]

Nutrients
Kiljańczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, Bryśkiewicz M, Cybulski C, Dębniak T, Gronwald J, Huzarski T, Lener MR, Jakubowska A, Cheriyan A, Szwiec M, Stawicka-Niełacna M, Godlewski D, Prusaczyk A, Jasiewicz A, Kluz T, Tomiczek-Szwiec J, Kilar-Kobierzycka E, Siołek M, Wiśniowski R, Posmyk R, Jarkiewicz-Tretyn J, Sun P, Scott RJ, Narod SA, Lubiński J.   +29 more
europepmc   +1 more source

Development of the Ontario Hereditary Cancer Research Network, a unified registry as a resource for individuals with inherited cancer syndromes: an observational registry creation protocol. [PDF]

BMJ Open
Farncombe KM, Hughes LK, Tuzlali E, Akbari MR, Andrulis IL, Aronson M, Bell K, Brazas MD, Cable-Cibula M, Chan B, Courtot M, Feilotter H, Harland J, Lark K, Lerner-Ellis J, MacDougall E, Malkin D, Narod SA, Panabaker K, Radvanyi L, Rusnak A, Stein L, Kim RH, OHCRN community.   +23 more
europepmc   +1 more source

Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers. [PDF]

Nutrients
Kiljańczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, Bryśkiewicz M, Lubiński K, Cybulski C, Dębniak T, Gronwald J, Huzarski T, Lener MR, Jakubowska A, Szwiec M, Stawicka-Niełacna M, Godlewski D, Prusaczyk A, Jasiewicz A, Kluz T, Tomiczek-Szwiec J, Kilar-Kobierzycka E, Siołek M, Wiśniowski R, Posmyk R, Jarkiewicz-Tretyn J, Sun P, Scott RJ, Narod SA, Lubiński J.   +29 more
europepmc   +1 more source

The MAGnetometers for Innovation and Capability (MAGIC) Technology Demonstration Payload. [PDF]

Space Sci Rev
Miles DM, Lasko A, Bounds S, Blandin MJ, Broadfoot R, Christian H, Dolan J, Dvorsky R, Finley MG, Flores AM, Greene K, Hinson G, Hisel S, Hogan C, Homann J, Kletzing CA, Morris KJ, Piker C, Smith Q, Steele KL, Strangeway RJ, Washington A.   +21 more
europepmc   +1 more source